S. Chocron et al., Intermediate lukewarm (20 degrees C) antegrade intermittent blood cardioplegia compared with cold and warm blood cardioplegia, J THOR SURG, 119(3), 2000, pp. 610-616
Citations number
21
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background: In the field of intermittent antegrade blood cardioplegia, 3 le
vels of temperature are commonly used: (1) cold (8 degrees C); (2) tepid (2
9 degrees C); and (3) warm (37 degrees C), Given the 21 degrees C spread an
d the metabolic changes that can occur between cold (8 degrees C) and tepid
(29 degrees C) cardioplegia, we thought it worthwhile to test a temperatur
e halfway between the cold and tepid levels. The aim of this study was to t
est the quality of myocardial protection provided by intermediate lukewarm
(20 degrees C) cardioplegia by comparing it with told and warm cardioplegia
. Protection was assessed by measuring cardiac troponin I release. Methods:
One hundred thirty-five patients undergoing coronary artery bypass graftin
g were enrolled in a prospective randomized trial comparing cold (8 degrees
C), intermediate lukewarm (20 degrees C), and warm (37 degrees C) antegrad
e intermittent blood cardioplegia. Cardiac troponin I concentrations were m
easured in serial venous blood samples, Results: The total amount of cardia
c troponin I released was significantly higher in the cold group (4.7 +/- 2
.3 mu g) than in the intermediate lukewarm (3.4 +/- 2.0 mu g) or the warm (
3.1 +/- 2.7 mu g) groups, The cardiac troponin I concentration was signific
antly higher at hour 6 in the intermediate lukewarm group (1.23 +/- 0.55 mu
g/L) than in the warm group (0.89 +/- 0.50 mu g/L). Conclusions: Intermitt
ent antegrade intermediate lukewarm blood cardioplegia is appropriate and c
linically safe, Cardiac troponin I release suggests that intermediate lukew
arm cardioplegia is better than cold cardioplegia but less effective than w
arm cardioplegia in low-risk patients, We therefore recommend the use of wa
rm cardioplegia in low-risk patients.